Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Joost Smolders, Nina L. Fransen, Cheng-Chih Hsiao, Jörg Hamann & Inge Huitinga. (2020) Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis. Expert Review of Neurotherapeutics 20:8, pages 835-848.
Read now
Read now
Vikram Bhise & Suhayl Dhib-Jalbut. (2016) Further understanding of the immunopathology of multiple sclerosis: impact on future treatments. Expert Review of Clinical Immunology 12:10, pages 1069-1089.
Read now
Read now
Articles from other publishers (19)
Matteo Zavarella, Andrea Villatore, Maria Assunta Rocca, Giovanni Peretto & Massimo Filippi. (2023) The Heart–Brain Interplay in Multiple Sclerosis from Pathophysiology to Clinical Practice: A Narrative Review. Journal of Cardiovascular Development and Disease 10:4, pages 153.
Crossref
Crossref
Andrea C. Diaz Diaz, Kyle Malone, Jennifer A. Shearer, Anne C. Moore & Christian Waeber. (2022) Preclinical Evaluation of Fingolimod in Rodent Models of Stroke With Age or Atherosclerosis as Comorbidities. Frontiers in Pharmacology 13.
Crossref
Crossref
L. Magy. (2022) Traitements de fond de la sclérose en plaques. État des lieux et perspectives. Bulletin de l'Académie Nationale de Médecine 206:6, pages 741-751.
Crossref
Crossref
Joana Ramos-Lopes, Sónia Batista, Pedro Barradas, Isabel Campelo, Inês Correia, Carla Nunes, Carmo Macário & Lívia Sousa. (2020) Clinical effectiveness of reduced fingolimod dose in relapsing remitting multiple sclerosis—a Portuguese cohort. Neurological Sciences 42:3, pages 1039-1043.
Crossref
Crossref
Abdullah Al Mamun, Ilma Monalisa, Khadija Tul Kubra, Afroza Akter, Jaheda Akter, Tamanna Sarker, Fahad Munir, Yanqing Wu, Chang Jia, Masuma Afrin Taniya & Jian Xiao. (2021) Advances in immunotherapy for the treatment of spinal cord injury. Immunobiology 226:1, pages 152033.
Crossref
Crossref
Gerasimos Rassias, Sofia Leonardi, Dionisia Rigopoulou, Eleanna Vachlioti, Konstantinos Afratis, Zoi Piperigkou, Christos Koutsakis, Nikos K. Karamanos, Haralambos Gavras & Dionissios Papaioannou. (2021) Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?. European Journal of Medicinal Chemistry 210, pages 112948.
Crossref
Crossref
Azadeh Yazdi, Maryam Ghasemi‐Kasman & Mohammad Javan. (2019) Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process. Journal of Neuroscience Research 98:3, pages 524-536.
Crossref
Crossref
Xiuxiang Liu, Jinjin Wu, Chenying Zhu, Jie Liu, Xiaoli Chen, Tao Zhuang, Yashu Kuang, Yanfang Wang, Hao Hu, Ping Yu, Huimin Fan, Yuzhen Zhang, Zhongmin Liu & Lin Zhang. (2019) Endothelial S1pr1 regulates pressure overload‐induced cardiac remodelling through AKT‐eNOS pathway. Journal of Cellular and Molecular Medicine 24:2, pages 2013-2026.
Crossref
Crossref
Edward J. FoxFred D. LublinJerry S. WolinskyJeffrey A. CohenIan M. WilliamsXiangyi MengMarina ZiehnScott KolodnyBruce A.C. Cree. (2019) Lymphocyte counts and infection rates. Neurology Neuroimmunology & Neuroinflammation 6:6.
Crossref
Crossref
Andrew R. Clark & Michael Ohlmeyer. (2019) Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration. Pharmacology & Therapeutics 201, pages 181-201.
Crossref
Crossref
Julika Pitsch, Julia C. Kuehn, Vadym Gnatkovsky, Johannes Alexander Müller, Karen M. J. van Loo, Marco de Curtis, Hartmut Vatter, Susanne Schoch, Christian E. Elger & Albert J. Becker. (2018) Anti-epileptogenic and Anti-convulsive Effects of Fingolimod in Experimental Temporal Lobe Epilepsy. Molecular Neurobiology 56:3, pages 1825-1840.
Crossref
Crossref
Guanghu Wang & Erhard Bieberich. (2018) Sphingolipids in neurodegeneration (with focus on ceramide and S1P). Advances in Biological Regulation 70, pages 51-64.
Crossref
Crossref
Raj Putatunda, John R. Bethea & Wen-Hui Hu. (2018) Potential immunotherapies for traumatic brain and spinal cord injury. Chinese Journal of Traumatology 21:3, pages 125-136.
Crossref
Crossref
Patrick Vermersch. (2018) Sphingosine-1-phosphate Receptor Modulators in Multiple Sclerosis. European Neurological Review 13:1, pages 25.
Crossref
Crossref
Yara Dadalti Fragoso, Tim Spelman, Cavit Boz, Raed Alroughani, Alessandra Lugaresi, Steve Vucic, Helmut Butzkueven, Murat Terzi, Eva Havrdova, Dana Horakova, Franco Granella, Javier Olascoaga, José Luis Sánchez-Menoyo, Eugenio Pucci, Michael Barnett, Joseph Bruno B. Brooks & Jodi Haartsen. (2018) Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod. Multiple Sclerosis and Related Disorders 19, pages 105-108.
Crossref
Crossref
Giancarlo Comi, Hans-Peter Hartung, Rajesh Bakshi, Ian M. Williams & Heinz Wiendl. (2017) Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis. Drugs 77:16, pages 1755-1768.
Crossref
Crossref
Burhan Z. Chaudhry, Jeffrey A. Cohen & Devon S. Conway. (2017) Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis. Neurotherapeutics 14:4, pages 859-873.
Crossref
Crossref
Rodolfo Thomé, Ana Carolina de Carvalho, Thiago Alves da Costa, Larissa Lumi Watanabe Ishikawa, Thais Fernanda de Campos Fraga‐Silva, Alexandrina Sartori, Alexandre Leite Rodrigues de Oliveira & Liana Verinaud. (2016) Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System. CNS Neuroscience & Therapeutics 22:8, pages 707-714.
Crossref
Crossref
Gerald J. Berry & Randall E. Morris. 2016. Pathology of Transplantation. Pathology of Transplantation
53
79
.